The phase 1/2 ACCEPT trial: concurrent cetuximab and intensity modulated radiation therapy with carbon ion boost for adenoid cystic carcinoma of the head and neck - Adeberg, Sebastian; Akbaba, Sati; Uzun-Lang, Kristin; Held, Thomas; Verma, Vivek; Nikoghosyan, Anna; Bernhardt, Denise; Münter, Marc; Freier, Kolja; Plinkert, Peter K.; Hauswald, Henrik; Herfarth, Klaus; et al. (International journal of radiation oncology, biology, physics, 2020)
Gesehen am 08.04.2020